Back to Search
Start Over
The secretin/secretin receptor axis modulates liver fibrosis through changes in TGF-β1 biliary secretion
- Publication Year :
- 2016
-
Abstract
- UNLABELLED The secretin/secretin receptor (SR) axis is up-regulated by proliferating cholangiocytes during cholestasis. Secretin stimulates biliary proliferation by down-regulation of let-7a and subsequent up-regulation of the growth-promoting factor, nerve growth factor (NGF). It is not known whether the secretin/SR axis plays a role in subepithelial fibrosis observed during cholestasis. Our aim was to determine the role of the secretin/SR axis in activation of biliary fibrosis in animal models and human primary sclerosing cholangitis (PSC). Studies were performed in wild-type (WT) mice with bile duct ligation (BDL), BDL SR(-/-) mice, or Mdr2(-/-) mouse models of cholestatic liver injury. In selected studies, the SR antagonist (Sec 5-27) was used to block the secretin/SR axis. Biliary proliferation and fibrosis were evaluated as well as secretion of secretin (by cholangiocytes and S cells), expression of markers of fibrosis, transforming growth factor-β1 (TGF-β1), transforming growth factor-β1 receptor (TGF-β1R), let-7a, and downstream expression of NGF. Correlative studies were performed in human control and PSC liver tissue biopsies, serum, and bile. SR antagonist reduced biliary proliferation and hepatic fibrosis in BDL WT and Mdr2(-/-) mice. There was decreased expression of let-7a in BDL and Mdr2(-/-) cholangiocytes that was associated with increased NGF expression. Inhibition of let-7a accelerated liver fibrosis was attributed to cholestasis. There was increased expression of TGF-β1 and TGF-β1R. Significantly higher expression of secretin, SR, and TGF-β1 was observed in PSC patient liver samples compared to healthy controls. In addition, there was higher expression of fibrosis genes and remarkably decreased expression of let-7a and increased expression of NGF compared to the control. CONCLUSION The secretin/SR axis plays a key role in regulating the biliary contribution to cholestasis-induced hepatic fibrosis. (Hepatology 2016;64:865-879).
- Subjects :
- Liver Cirrhosis
Male
0301 basic medicine
Receptor, Transforming Growth Factor-beta Type I
Receptors, G-Protein-Coupled
Secretin
0302 clinical medicine
Fibrosis
MED/12 - GASTROENTEROLOGIA
Mice, Knockout
microRNA
biliary fibrosis
Middle Aged
Liver
Secretin receptor
Female
030211 gastroenterology & hepatology
medicine.medical_specialty
Cholangitis, Sclerosing
Protein Serine-Threonine Kinases
Biology
digestive system
nerve growth factor
Article
Cell Line
Receptors, Gastrointestinal Hormone
Primary sclerosing cholangitis
Transforming Growth Factor beta1
cholangiocytes
cholestasis
03 medical and health sciences
Cholestasis
Internal medicine
medicine
Animals
Humans
Biliary Fibrosi
Hepatology
medicine.disease
digestive system diseases
Fibronectins
Mice, Inbred C57BL
MicroRNAs
030104 developmental biology
Nerve growth factor
Endocrinology
Case-Control Studies
Hepatic fibrosis
Receptors, Transforming Growth Factor beta
Cholangiocyte
Transforming growth factor
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....57cb212708821754a9493f40cb125cfb